Optimizing Prostate Cancer Screening for Individuals – A Decision-Analytic view on Personalized Benefit-Harm Balance

Nikolai Mühlberger, Eva Esteban, Eveline A.M. Heijnsdijk, Willi Oberaigner, Gaby Sroczynski, Beate Jahn & Uwe Siebert
Background and Objective: Prostate cancer is the most frequently diagnosed male malignancy and the 3rd most frequent cause for male cancer death in Germany. Early detection and treatment is the only option to reduce prostate cancer mortality, but gains in life expectancy are opposed by losses in quality[for full text, please go to the a.m. URL]